HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Strategic Documents Outline Regulatory Science Priorities

This article was originally published in The Tan Sheet

Executive Summary

Improving regulatory tools and scientific know-how are among FDA's top priorities over the next five years, according to a draft strategic report

You may also be interested in...



FDA’s Regulatory Science Next Steps Include Food Safety Enforcement

FDA plans to invest in eight priority areas for regulatory science, including prevention-focused food safety enforcement and better tools for reviewing manufacturing systems, according to a strategic plan.

Congress extends federal funding temporarily

Congress Sept. 30 passes a continuing resolution maintaining funding for FDA and other federal agencies at fiscal 2010 levels. The CR expires Dec. 3. If Republicans win a majority in the midterm elections in November, during the subsequent lame-duck session they might force passage of another CR that would the allow the party to set fiscal 2011 spending levels after the 112th Congress begins in January

FDA Commissioner Sees Industry Role In Regulatory Science Initiative

Drug and device firms should have a seat at the table as FDA strengthens its regulatory science program and thus speeds pre-market product reviews, Commissioner Margaret Hamburg says

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS135477

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel